Compare Merck Tbk. (MERK) vs Tripar Multivision Plus Tbk. (RAAM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck Tbk. vs Tripar Multivision Plus Tbk. — how do they compare? Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume), while Tripar Multivision Plus Tbk. trades at Rp206 (market cap 1.36T, 1.13M 24h volume). The key difference: Merck Tbk. is the larger of the two by market cap, and Tripar Multivision Plus Tbk. is more actively traded (1.13M versus 37.6K). Which is the better fit depends on your goals.
| MERK | RAAM | |
|---|---|---|
Market Cap | 1.7T | 1.36T |
Volume | 37.6K | 1.13M |
Lot | 376 | 11.26K |
Turnover | 144.47M | 231.39M |
Average Price | 3,842.23 | 205.46 |
Value | 144.47M | 231.39M |
Indicative Equilibrium Price | 3,840 | 206 |
Indicative Equilibrium Volume | 7 | 173 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →About Tripar Multivision Plus Tbk.
PT Tripar Multivision Plus Tbk (“the Company”) was establishedbased on Deed of Establishment of Limited Liability Company No. 17 dated 6 December 1990 drawn up before Adlan Yulizar, S.H., notary in Jakarta.
Read more on RAAM →
